Center for iPS Cell Research and Application, Kyoto University (CiRA), where Nobel prize winner Professor Shinya Yamanaka serves as the Director, released the latest newsletter Vol. 45 (April 2021). The issue entitled “Researchers confronting COVID-19 – iPS cells open the possibility of therapies” introduces researchers conducting the research to develop therapies for the novel coronavirus infection using iPS cells. Professor Hiroshi Kawamoto, an executive director of Rebirthel and the Vice Director of Institute for Frontier Life and Medical Sciences, Kyoto University, is
largely featured together with Associate Professor Megumu K. Saito, Department of Clinical Application, CiRA. The article is in a conversational style between Professor Kawamoto and Associate Professor. It explains that Rebirthel is aiming to realize cell-based therapies against cancers and infectious diseases using Professor Kawamoto’s technology.
Link to the article (Only in Japanese) http://kawamoto.frontier.kyoto-u.ac.jp/common/images/diary%20data/2021/210512Newsletter_Vol_45.pdf